176 related articles for article (PubMed ID: 203869)
1. Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.
Pieri L; Keller HH; Burkard W; Da Prada M
Nature; 1978 Mar; 272(5650):278-80. PubMed ID: 203869
[No Abstract] [Full Text] [Related]
2. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
[No Abstract] [Full Text] [Related]
3. Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome".
Silbergeld EK; Hruska RE
Psychopharmacology (Berl); 1979 Nov; 65(3):233-7. PubMed ID: 117494
[No Abstract] [Full Text] [Related]
4. Acute changes in central serotonin metabolism induced by the blockade or stimulation of serotoninergic receptors during ontogenesis in the rat.
Bourgoin S; Artaud F; Enjalbert A; Héry F; Glowinski J; Hamon M
J Pharmacol Exp Ther; 1977 Sep; 202(3):519-31. PubMed ID: 894519
[No Abstract] [Full Text] [Related]
5. Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain.
Kehr W; Speckenbach W
Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):163-9. PubMed ID: 305542
[No Abstract] [Full Text] [Related]
6. Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines.
Sherry RL; Baker GB; Coutts RT
Biol Psychiatry; 1990 Sep; 28(6):539-43. PubMed ID: 1699613
[No Abstract] [Full Text] [Related]
7. Response of central monoaminergic neurons to lisuride: comparison with LSD.
Rogawski MA; Aghajanian GK
Life Sci; 1979 Apr; 24(14):1289-97. PubMed ID: 470543
[No Abstract] [Full Text] [Related]
8. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
White FJ; Appel JB
Science; 1982 Apr; 216(4545):535-7. PubMed ID: 7071600
[TBL] [Abstract][Full Text] [Related]
9. [Action of UML on levels of 5HT and 5HIAA in the rat brain with MAO blocking].
Torre M; Torre E; Bogetto F
Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1876-9. PubMed ID: 1027452
[No Abstract] [Full Text] [Related]
10. [Monoamines (3): postmortem studies on the human brain in a suicide group].
Gottfries CG; Winblad B
Lakartidningen; 1978 Feb; 75(8):663-5. PubMed ID: 634000
[No Abstract] [Full Text] [Related]
11. Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions.
White FJ
Pharmacol Biochem Behav; 1986 Feb; 24(2):365-79. PubMed ID: 3952127
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms by which quipazine, a putative serotonin receptor agonist, alters brain 5-hydroxyindole metabolism.
Jacoby JH; Howd RA; Levin MS; Wurtman RJ
Neuropharmacology; 1976 Sep; 15(9):529-34. PubMed ID: 980228
[No Abstract] [Full Text] [Related]
13. Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine.
Peters DA
Biochem Pharmacol; 1974 Jan; 23(2):231-7. PubMed ID: 4149793
[No Abstract] [Full Text] [Related]
14. Biogenic amine-containing neurons: biochemical mechanisms of synaptic transmission.
Neff NG; Yang HY; Garelis E; Sampath SS
Psychother Psychosom; 1974; 23(1-6):159-68. PubMed ID: 4369812
[No Abstract] [Full Text] [Related]
15. LSD: effect on monoamine metabolites in rat prefrontal cortex.
Bowers MB; Salomonsson LA
Biochem Pharmacol; 1982 Dec; 31(24):4093-6. PubMed ID: 6186259
[No Abstract] [Full Text] [Related]
16. Neurotransmitters in the brains of patients with dementia disorders.
Gottfries CG
Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
[No Abstract] [Full Text] [Related]
17. Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions.
Fink H; Morgenstern R
Psychopharmacology (Berl); 1985; 85(4):464-8. PubMed ID: 2991961
[TBL] [Abstract][Full Text] [Related]
18. Turning in MFB-lesioned rats and antagonism of neuroleptic-induced catalepsy after lisuride and LSD.
Pieri M; Schaffner R; Pieri L; Da Prada M; Haefely W
Life Sci; 1978 May; 22(18):1615-22. PubMed ID: 307642
[No Abstract] [Full Text] [Related]
19. Ca2+ channel blockade prevents lysergic acid diethylamide-induced changes in dopamine and serotonin metabolism.
Antkiewicz-Michaluk L; Románska I; Vetulani J
Eur J Pharmacol; 1997 Jul; 332(1):9-14. PubMed ID: 9298920
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of LSD and lisuride on A10 dopamine neurons in the rat.
White FJ; Wang RY
Neuropharmacology; 1983 Jun; 22(6):669-76. PubMed ID: 6888664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
